Suboptimal moxifloxacin and levofloxacin drug exposure during treatment of patients with multidrug-resistant tuberculosis: results from a prospective study in China.
Eur Respir J
; 57(3)2021 03.
Article
in En
| MEDLINE
| ID: mdl-33154028
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pharmaceutical Preparations
/
Tuberculosis, Multidrug-Resistant
/
Mycobacterium tuberculosis
Type of study:
Observational_studies
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Eur Respir J
Year:
2021
Document type:
Article
Affiliation country:
Sweden
Country of publication:
United kingdom